BELLUS Health inc. announces completion of first tranche of financing

    LAVAL, QC, April 16 /CNW Telbec/ - Further to the press releases of March
31 and April 8, 2009, BELLUS Health Inc. ("BELLUS Health") (TSX: BLU) is
pleased to announce the completion of the first tranche of its previously
announced Cdn. $20.5 million financing.
    BELLUS Health received gross proceeds of Cdn. $10 million for the
issuance of new convertible notes (Cdn.$5 million from Vitus Investments III
Private Limited and Cdn.$5 million from Victoria Square Ventures Inc.) and a
second tranche of Cdn.$10.5 (Cdn.$5 million from Vitus Investments III Private
Limited and Cdn.$5.5 million from Victoria Square Ventures Inc.) is expected
to be funded in June 2009.

    About BELLUS Health

    BELLUS Health is a global health company focused on the development and
commercialization of products to provide innovative health solutions to
address critical unmet needs.

    To Contact BELLUS Health

    For additional information on BELLUS Health and its drug development
programs, please call the Canada and United States toll-free number
1-877-680-4500 or visit the Web Site at

    Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond BELLUS Health
Inc.'s control. Such risks include but are not limited to: the ability to
obtain financing immediately in the current markets, the impact of general
economic conditions, general conditions in the pharmaceutical and/or
nutraceutical industry, changes in the regulatory environment in the
jurisdictions in which the BELLUS Health Group does business, stock market
volatility, the availability and terms of any financing, fluctuations in
costs, and changes to the competitive environment due to consolidation, that
actual results may vary once the final and quality-controlled verification of
data and analyses has been completed, as well as other risks disclosed in
public filings of BELLUS Health Inc. Consequently, actual future results may
differ materially from the anticipated results expressed in the
forward-looking statements. The reader should not place undue reliance, if
any, on any forward-looking statements included in this news release. These
statements speak only as of the date made and BELLUS Health Inc. is under no
obligation and disavows any intention to update or revise such statements as a
result of any event, circumstances or otherwise, unless required by applicable
legislation or regulation. Please see the Annual Information Form of BELLUS
Health Inc. for further risk factors that might affect the BELLUS Health Group
and its business.

For further information:

For further information: Mariano Rodriguez, CA, CPA, Vice President,
Finance, and Chief Financial Officer, (450) 680-4572,

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890